Low levels of the amino acid arginine disrupt a crucial cellular warning system, allowing cancer and viral infections to evade immune detection, according to a study published in the journal Cell by researchers at Rockefeller University.
Arginine Levels Affect MHC-I Production and Disease Severity
- MHC-I Production: When cells run low on arginine, ribosomes (cellular protein builders) stall while trying to manufacture MHC-I proteins, which normally act as warning flags for the immune system.
- Dietary Impact: Animal experiments show that increasing dietary arginine reduces colon cancer tumor formation and lessens the severity of influenza and SARS-CoV-2 infections.
- Therapeutic Potential: Researchers suggest that inexpensive arginine supplementation could eventually be tested alongside existing cancer immunotherapies or given to high-risk viral populations, though human clinical trials are still required.
Rockefeller University Findings on Arginine and Immunity
Scientists at Rockefeller University have identified a direct link between nutritional amino acid availability and the immune system’s ability to recognize serious threats. Arginine is an essential amino acid that the body produces naturally and obtains from protein-rich foods. Researchers have long said that unusually low arginine levels accompany several diseases, including colon cancer. However, the exact mechanism behind how this shortage impairs bodily defenses remained unclear until now.
The research was led by Sohail Tavazoie. His team previously discovered in research published in Science Advances that depriving colon cancer cells of arginine caused them to accumulate genetic mutations. Building on that work, the latest study published in Cell examines how arginine scarcity impacts protein production across multiple disease models, ScienceDaily reported.
“Arginine supplementation could be readily tested in patients receiving immunotherapies or given to high-risk populations exposed to viral pathogens,” Tavazoie suggested.
“One of the most dramatic patterns to emerge was that arginine was the most depleted amino acid in all of these diseases,” said Qiushuang Wu, a postdoc in the lab, told ScienceDaily.
Molecular Mechanism of Immune Evasion
To understand the cellular impact, Wu examined how arginine shortages affect protein synthesis. The analysis identified 414 proteins whose levels dropped when arginine was scarce, including three genes from the HLA family responsible for producing MHC-I (major histocompatibility complex class I) proteins.
MHC-I molecules display small protein fragments on cell surfaces, allowing T cells to identify internal abnormalities such as viral proteins or cancer mutations. When arginine is unavailable, ribosomes stall during the assembly of these specific proteins because MHC-I production requires arginine at numerous points. Consequently, fewer MHC-I molecules reach the cell surface, reducing the molecular warning signals that alert T cells to danger.
“Our work reveals how a lack of arginine interferes with the immune system, and suggests that upping arginine intake could prove beneficial,” Wu told ScienceDaily, noting it could potentially combine with other therapies.
Dietary Arginine in Mouse Models of Cancer and Viruses
Following the identification of this molecular bottleneck, the research team tested whether modifying dietary arginine influenced disease outcomes in mice. Animals receiving low-arginine diets developed more colon cancer tumors, whereas mice consuming higher amounts developed fewer tumors. These results indicated that arginine availability directly alters immune-mediated cancer surveillance rather than merely changing individual cancer cell behavior.
In subsequent experiments conducted with Heinz-Heinrich Hoffman, a research assistant professor in Charles Rice’s Laboratory of Virology and Infectious Disease, researchers tested dietary arginine in mouse models of influenza and SARS-CoV-2. Mice consuming more arginine experienced less severe symptoms from both viral infections. Administering arginine after mice had already contracted influenza also improved their recovery outcomes.
“Not only did mice with an arginine-rich diet have milder symptoms from viral infections, giving the mice arginine after influenza infection improved their outcomes too,” Wu told ScienceDaily.
Contraindications & When to Consult a Doctor
Clinical trials in humans are required before any formal therapeutic guidelines can be established.
References
- Wu, Q., et al. (2026). Dietary arginine regulates MHC-I expression and immune response. Cell.
- Rockefeller University Laboratory of Systems Cancer Biology.
- Stavros Niarchos Foundation (SNF) Institute for Global Infectious Disease Research at The Rockefeller University.
